Investment Portfolio | ||||||||
(UNAUDITED) | 01.31.2021 | ||||||||
CARILLON SCOUT SMALL CAP FUND | ||||||||
COMMON STOCKS - 99.6% | Shares | Value | ||||||
Aerospace & defense - 1.6% | ||||||||
Kratos Defense & Security Solutions, Inc.* | 243,820 | $ | 6,470,983 | |||||
Air freight & logistics - 0.9% | ||||||||
Forward Air Corp. | 51,976 | 3,726,159 | ||||||
Auto components - 1.4% | ||||||||
Patrick Industries, Inc. | 18,203 | 1,257,099 | ||||||
Stoneridge, Inc.* | 163,379 | 4,484,754 | ||||||
Automobiles - 1.4% | ||||||||
Thor Industries, Inc. | 48,582 | 5,878,908 | ||||||
Banks - 0.8% | ||||||||
Hilltop Holdings, Inc. | 111,486 | 3,349,039 | ||||||
Biotechnology - 7.6% | ||||||||
Coherus Biosciences, Inc.* | 182,303 | 3,427,296 | ||||||
Eagle Pharmaceuticals, Inc.* | 76,943 | 3,590,930 | ||||||
Halozyme Therapeutics, Inc.* | 176,785 | 8,413,198 | ||||||
Insmed, Inc.* | 170,676 | 6,415,711 | ||||||
Vericel Corp.* | 230,830 | 9,526,354 | ||||||
Capital markets - 1.8% | ||||||||
Cohen & Steers, Inc. | 95,480 | 6,253,940 | ||||||
Open Lending Corp., Class A* | 31,451 | 1,141,357 | ||||||
Chemicals - 1.2% | ||||||||
Balchem Corp. | 47,500 | 5,083,925 | ||||||
Commercial services & supplies - 0.9% | ||||||||
Healthcare Services Group, Inc. | 117,711 | 3,816,191 | ||||||
Construction & engineering - 1.3% | ||||||||
Dycom Industries, Inc.* | 64,018 | 5,194,421 | ||||||
Consumer finance - 2.5% | ||||||||
Green Dot Corp., Class A* | 54,384 | 2,731,709 | ||||||
LendingTree, Inc.* | 16,587 | 5,399,400 | ||||||
PRA Group, Inc.* | 73,126 | 2,410,964 | ||||||
Electrical equipment - 2.4% | ||||||||
TPI Composites, Inc.* | 165,118 | 9,892,219 | ||||||
Electronic equipment, instruments & components - 5.6% | ||||||||
ePlus, Inc.* | 51,242 | 4,306,378 | ||||||
Fabrinet* | 61,435 | 4,849,679 | ||||||
II-VI, Inc.* | 113,207 | 9,517,312 | ||||||
Plexus Corp.* | 59,260 | 4,558,279 | ||||||
Energy equipment & services - 0.3% | ||||||||
Core Laboratories N.V. | 40,999 | 1,352,147 | ||||||
Equity real estate investment trusts (REITs) - 1.7% | ||||||||
CareTrust REIT, Inc. | 137,439 | 3,086,880 | ||||||
QTS Realty Trust, Inc., Class A | 62,055 | 4,039,780 | ||||||
Food & staples retailing - 1.4% | ||||||||
Performance Food Group Co.* | 126,692 | 5,939,321 | ||||||
Health care equipment & supplies - 4.7% | ||||||||
Cantel Medical Corp.* | 42,963 | 3,392,788 | ||||||
ICU Medical, Inc.* | 27,740 | 5,672,275 | ||||||
Integer Holdings Corp.* | 68,202 | 5,033,308 | ||||||
LeMaitre Vascular, Inc. | 74,877 | 3,598,589 | ||||||
Varex Imaging Corp.* | 99,026 | 1,917,143 | ||||||
Health care providers & services - 10.6% | ||||||||
AdaptHealth Corp.* | 218,249 | 8,352,389 | ||||||
AMN Healthcare Services, Inc.* | 95,499 | 6,887,388 | ||||||
BioTelemetry, Inc.* | 48,742 | 3,483,103 | ||||||
HealthEquity, Inc.* | 86,798 | 7,251,973 | ||||||
LHC Group, Inc.* | 42,234 | 8,413,858 | ||||||
ModivCare, Inc.* | 20,673 | 3,278,118 | ||||||
U.S. Physical Therapy, Inc. | 54,049 | 6,504,257 | ||||||
Health care technology - 3.2% | ||||||||
HMS Holdings Corp.* | 70,038 | 2,578,799 | ||||||
Omnicell, Inc.* | 90,844 | 10,701,423 | ||||||
Hotels, restaurants & leisure - 2.2% | ||||||||
Cracker Barrel Old Country Store, Inc. | 24,552 | 3,322,131 | ||||||
Lindblad Expeditions Holdings, Inc.* | 161,060 | 2,528,642 | ||||||
The Cheesecake Factory, Inc. | 75,410 | 3,391,188 | ||||||
Household durables - 3.4% | ||||||||
Installed Building Products, Inc.* | 66,337 | 6,960,741 | ||||||
iRobot Corp.* | 11,451 | 1,375,265 | ||||||
LGI Homes, Inc.* | 54,052 | 5,767,889 | ||||||
Insurance - 0.7% | ||||||||
CNO Financial Group, Inc. | 137,939 | 2,925,686 | ||||||
Internet & direct marketing retail - 3.2% | ||||||||
Magnite, Inc.* | 334,814 | 11,597,957 | ||||||
PetMed Express, Inc. (a) | 46,599 | 1,780,082 | ||||||
IT Services - 1.1% | ||||||||
I3 Verticals, Inc., Class A* | 155,914 | 4,524,624 | ||||||
Life sciences tools & services - 6.9% | ||||||||
Bruker Corp. | 133,152 | 7,708,169 | ||||||
Medpace Holdings, Inc.* | 60,484 | 8,031,670 | ||||||
NeoGenomics, Inc.* | 126,632 | 6,714,029 | ||||||
PRA Health Sciences, Inc.* | 51,763 | 6,379,272 | ||||||
Machinery - 5.5% | ||||||||
Albany International Corp., Class A | 58,789 | 4,087,011 | ||||||
Chart Industries, Inc.* | 85,409 | 10,258,475 | ||||||
Proto Labs, Inc.* | 39,558 | 8,378,385 | ||||||
Pharmaceuticals - 1.2% | ||||||||
Supernus Pharmaceuticals, Inc.* | 168,408 | 4,949,511 | ||||||
Professional services - 1.4% | ||||||||
Insperity, Inc. | 72,539 | 5,693,586 | ||||||
Semiconductors & semiconductor equipment - 8.1% | ||||||||
Advanced Energy Industries, Inc.* | 46,677 | 4,788,127 | ||||||
Ambarella, Inc.* | 59,817 | 5,644,332 | ||||||
Impinj, Inc.* | 77,322 | 4,095,746 | ||||||
Inphi Corp.* | 39,519 | 6,663,299 | ||||||
Power Integrations, Inc. | 70,312 | 5,663,632 | ||||||
Semtech Corp.* | 98,391 | 6,980,841 | ||||||
Software - 9.1% | ||||||||
Box, Inc., Class A* | 199,682 | 3,462,486 | ||||||
Envestnet, Inc.* | 66,012 | 5,065,101 | ||||||
J2 Global, Inc.* | 61,998 | 6,363,475 | ||||||
Qualys, Inc.* | 40,877 | 5,660,238 | ||||||
The Descartes Systems Group, Inc.* | 98,511 | 6,015,082 | ||||||
Upland Software, Inc.* | 122,914 | 5,861,769 | ||||||
Verint Systems, Inc.* | 71,779 | 5,299,443 | ||||||
Specialty retail - 1.2% | ||||||||
Monro, Inc. | 83,024 | 4,854,413 | ||||||
Textiles, apparel & luxury goods - 1.0% | ||||||||
G-III Apparel Group Ltd.* | 161,106 | 4,356,306 | ||||||
Thrifts & mortgage finance - 1.0% | ||||||||
Axos Financial, Inc.* | 103,938 | 4,048,385 | ||||||
Trading companies & distributors - 2.3% | ||||||||
Applied Industrial Technologies, Inc. | 57,830 | 4,070,654 | ||||||
Systemax, Inc. | 139,245 | 5,351,185 | ||||||
Total common stocks (cost $217,856,479) | 413,798,571 | |||||||
MONEY MARKET FUNDS - 0.0% | ||||||||
First American Government Obligations Fund - Class X, 0.04%# | 3,120 | 3,120 | ||||||
Total money market funds (cost $3,120) | 3,120 | |||||||
Total Investment portfolio (cost $217,859,599) - 99.6% | 413,801,691 | |||||||
Other assets in excess of liabilities - 0.4% | 1,534,414 | |||||||
Total net assets - 100.0% | $ | 415,336,105 |
* Non-income producing security | ||||
(a) All or a portion of this security was on loan as of the date of this report. The total fair market value of loaned securities was $3,056 or 0.0% of net assets as of the date of this report. | ||||
# Annualized seven-day yield as of the date of this report. Investment made with cash collateral received for securities on loan. | ||||
Fair value measurements | The Fund utilizes a three-level hierarchy of inputs to establish a classification of fair value measurements. The three levels are defined as: | ||||
Level 1—Valuations based on unadjusted quoted prices for identical securities in active markets; | ||||
Level 2—Valuations based on inputs other than quoted prices that are observable, either directly or indirectly, including inputs in markets that are not considered active; and | ||||
Level 3—Valuations based on inputs that are unobservable and significant to the fair value measurement, and may include the Valuation Committee’s own assumptions on determining fair value of investments. | ||||
Inputs that are used in determining fair value of an investment may include price information, credit data, volatility statistics, and other factors. These inputs can be either observable or unobservable. The availability of observable inputs can vary between investments and is affected by various factors such as the type of investment and the volume and/or level of activity for that investment or similar investments in the marketplace. The inputs will be considered by the Valuation Committee, along with any other relevant factors in the calculation of an investment’s fair value. The Fund uses prices and inputs that are current as of the valuation date, which may include periods of market dislocations. During these periods, the availability of prices and inputs may be reduced for many investments. This condition could cause an investment to be reclassified between the various levels within the hierarchy. Investments falling into the Level 3 category may be classified as such due to a lack of market transparency and corroboration to support the quoted prices. Additionally, valuation models may be used as the pricing source for any remaining investments classified as Level 3. These models may rely on one or more significant unobservable inputs and/or significant assumptions by the Valuation Committee. Inputs used in valuations may include, but are not limited to, financial statement analysis, capital account balances, discount rates and estimated cash flows, and comparable entity data. | ||||
All investments are categorized as Level 1 as of the date of this report. | ||||
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual report. | ||||
The Global Industry Classification Standard (GICS®) was developed by and/or is the exclusive property of Morgan Stanley Capital International, Inc. (“MSCI”) and Standard & Poor’s Financial Services LLC (“S&P”). GICS is a service mark of MSCI and S&P and has been licensed for use by U.S. Bancorp Fund Services, LLC. |